Securities
Securities Exchange Act
In re: Vaxart Inc. Securities Litigation
Published: Nov. 18, 2022 | Result Date: Sep. 15, 2022 |Case number: 3:20-cv-05949-VC Settlement – $12,015,000
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Already a subscriber?
Sign In